ALLMedicine™ Nail Disorders Center
Research & Reviews 76 results
Clinical and Experimental Dermatology; Starace M, Alessandrini A et. al.
Feb 5th, 2022 - Nail disorders in general are difficult to treat and often frustrating, and this is also the case with nail psoriasis, especially when it is limited to the nails, and not affecting joints. The quality of life of patients with nail psoriasis is neg...
Journal of the European Academy of Dermatology and Venere... Darmawan CC, Ohn J et. al.
Feb 1st, 2022 - Nail melanoma (NM) is an important differential diagnosis in patients with longitudinal melanonychia. However, diagnosis is often challenging as it is difficult to differentiate from other pigmented nail disorders. The main challenge for diagnosis...
Journal of Cosmetic Dermatology; Abu El-Hamd M, Yassin FESE et. al.
Nov 23rd, 2021 - This study aimed to assess the possible role of dermoscopy in the diagnosis of different nail disorders compared with the clinical and histopathological diagnosis. This study included 104 patients with nail disorders of both sex and any age. All t...
Clinics in Dermatology; Muddasani S, Lin G et. al.
Nov 18th, 2021 - The nail is a specialized keratinous skin appendage that is often overlooked, even though nail disorders comprise approximately 10% of all dermatologic conditions. We provide an overview on the basic anatomy of the nail and function of each struct...
https://doi.org/10.1007/s40257-021-00645-0 10.1200/EDBK_289911 10.1634/theoncologist.2019-0250 10.1111/jdv.16159 10.1016/S0140-6736(20)32381-3 10.1002/onco.13531 10.1002/onco.13684 10.1007/s40264-021-01071-1 10.1007/s10549-021-06169-9 10.1007/s10549-020-05914-w 10.4048/jbc.2021.24.e1 10.4048/jbc.2019.22.e44 10.1016/j.jdcr.2021.05.028 10.1111/bjd.19677 10.1007/s11523-020-00738-6 10.3390/cancers13081758 10.1007/s10549-020-06001-w 10.1001/jamadermatol.2020.3385 10.1007/s40257-021-00625-4 10.1016/j.jaad.2021.04.092 10.1016/j.annonc.2020.11.005 10.1111/bcp.13098 10.1007/s40264-017-0594-2 10.1007/s40257-018-0384-3 10.1111/jdv.15508 10.1007/s40257-020-00505-3 10.1016/S0140-6736(18)31770-7 10.1016/S1470-2045(19)30804-6 10.1177/1758835918793326 10.1007/s10549-019-05261-5 10.1016/j.jaad.2018.04.046 10.1016/j.jclinepi.2021.01.015
American Journal of Clinical Dermatology; Raschi E, Fusaroli M et. al.
Oct 27th, 2021 - Cyclin-dependent kinase (CDK)-4/6 inhibitors have been associated with dermatologic reactions, especially alopecia, in pivotal trials. We aimed to comprehensively describe skin toxicities with CDK4/6 inhibitors reported in the real world through t...
Drugs 5 results see all →
Clinicaltrials.gov 1 results
Apr 18th, 2018 - Lymphedema is the result of an intra-tissue fluid accumulation by failure of the lymphatic system to absorb the excess fluid from the veinulo-capillary circulation. Lymphedema can be primitive with aplasia or hypoplasia of the lymphatic vessels or...
News 17 results
Sep 10th, 2021 - Talquetamab, an off-the-shelf T-cell redirecting, GP3C5D-targeting agent, has continued to show promising clinical activity in patients with relapsed/refractory multiple myeloma, especially when given at the recommended phase 2 dose (RP2D) of 405 ...
Cynthia X. Chan, MD, Daniel M. Siegel, MD, MS et. al.
Aug 11th, 2021 - Mobile applications (apps) have been a growing part of medicine for the last decade. In 2020, more than 15.
Stephanie Ishack, PhD, Shari R. Lipner, MD, PhD
Mar 9th, 2021 - The use of mobile devices in health care settings has enhanced clinical practice through real-time communication and direct patient monitoring. 1 With advancements in technology, improving the accessibility and quality of patient care using mobile.
Dec 20th, 2020 - The off-the-shelf DuoBody® IgG4 PAA binding antibody talquetamab has elicited a high response rate with a tolerable safety profile in heavily pretreated patients with relapsed/refractory multiple myeloma, according to early data from a phase 1 tri...
Jason J. John, BS, Shari R. Lipner, MD, PhD
Apr 3rd, 2019 - Patients frequently present to dermatologists with nail disorders as their chief concern. Alternatively, nail conditions may be encountered by the examining physician as an incidental finding that may be a clue to underlying systemic disease.